Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2705)
All Articles published online
|
Mar 27, 2010 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Porta C, Paglino C. Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib. World J Hepatol 2010; 2(3): 103-113 [PMID: 21160981 DOI: 10.4254/wjh.v2.i3.103] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v2/i3/103.htm |
| Number | Citing Articles |
| 1 |
Camillo Porta, Palma Giglione, Alessandra Ferrari, Francesca Reversi, Wanda Liguigli, Ilaria Imarisio, Carlo Ganini. Tivantinib (ARQ197) in hepatocellular carcinoma. Expert Review of Anticancer Therapy 2015; 15(6): 615 doi: 10.1586/14737140.2015.1050383
|
| 2 |
Kanchan Vishnoi, Rong Ke, Karan S. Saini, Navin Viswakarma, Rakesh Sathish Nair, Subhasis Das, Zhengjia Chen, Ajay Rana, Basabi Rana. Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells. Molecular Pharmacology 2021; 99(1): 1 doi: 10.1124/molpharm.120.000029
|
| 3 |
P. Fitzmorris, M. Shoreibah, B. S. Anand, A. K. Singal. Management of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2015; 141(5): 861 doi: 10.1007/s00432-014-1806-0
|
| 4 |
Xuelian Zhao, Lynne W Elmore, Curtis C Harris, Xin Wei Wang. Encyclopedia of Life Sciences. 2011; doi: 10.1002/9780470015902.a0006112.pub2
|
| 5 |
Xin Xie, Yiran Zhou, Xue Wang, Jian Guo, Jingwen Li, Hongye Fan, Jie Dou, Baiyong Shen, Changlin Zhou. Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivo. Carbohydrate Polymers 2017; 173: 360 doi: 10.1016/j.carbpol.2017.06.024
|
| 6 |
Carmen Berasain, María Ujue Latasa, Raquel Urtasun, Saioa Goñi, María Elizalde, Oihane Garcia-Irigoyen, María Azcona, Jesús Prieto, Matías A. Ávila. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer. Cancers 2011; 3(2): 2444 doi: 10.3390/cancers3022444
|
| 7 |
Rie Matsushima‐Nishiwaki, Seiji Adachi, Takashi Yoshioka, Eisuke Yasuda, Yasumasa Yamagishi, Junya Matsuura, Masato Muko, Rutsu Iwamura, Takahiro Noda, Hidenori Toyoda, Yuji Kaneoka, Yukio Okano, Takashi Kumada, Osamu Kozawa. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen‐activated protein kinases and AKT pathways. Journal of Cellular Biochemistry 2011; 112(11): 3430 doi: 10.1002/jcb.23270
|
| 8 |
Christopher L. Daige, Jason F. Wiggins, Leslie Priddy, Terri Nelligan-Davis, Jane Zhao, David Brown. Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer. Molecular Cancer Therapeutics 2014; 13(10): 2352 doi: 10.1158/1535-7163.MCT-14-0209
|
| 9 |
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
|
| 10 |
Ronnie TP Poon, Nicholas Borys. Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer. Future Oncology 2011; 7(8): 937 doi: 10.2217/fon.11.73
|
| 11 |
I Fasolino, V Guarino, M Marrese, V Cirillo, M Vallifuoco, M L Tamma, V Vassallo, A Bracco, F Calise, L Ambrosio.
HepG2 and human healthy hepatocyte
in vitro
culture and co-culture in PCL electrospun platforms
. Biomedical Materials 2017; 13(1): 015017 doi: 10.1088/1748-605X/aa8c51
|